|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/05 | (2006.01) |
| A61K 36/185 | (2013.01) | ||
| A61K 36/185 | (2006.01) | ||
| A61K 31/05 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 25/08 | (2018.01) | ||
| A61P 25/08 | (2006.01) | ||
| A61K 45/06 | (2013.01) |
| (11) | Patento numeris | 3888641 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21166413.1 |
| Europos patento paraiškos padavimo data | 2015-10-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-10-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-09-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201418169 | 2014-10-14 | GB |
| (72) |
GUY, Geoffrey , GB
WRIGHT, Stephen , GB
MEAD, Alice , GB
DEVINSKY, Orrin , US
|
| (73) |
Jazz Pharmaceuticals Research UK Limited ,
Building 730 Kent Science Park, Sittingbourne Kent ME9 8AG,
GB
|
| (54) | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH DOOSE SYNDROME |
| USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH DOOSE SYNDROME |